1. Home
  2. AMPL vs BHVN Comparison

AMPL vs BHVN Comparison

Compare AMPL & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitude Inc.

AMPL

Amplitude Inc.

HOLD

Current Price

$7.51

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.82

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPL
BHVN
Founded
2012
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
AMPL
BHVN
Price
$7.51
$11.82
Analyst Decision
Strong Buy
Buy
Analyst Count
12
14
Target Price
$13.50
$27.69
AVG Volume (30 Days)
2.9M
2.0M
Earning Date
05-20-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
11.84
N/A
EPS
N/A
N/A
Revenue
$343,214,000.00
N/A
Revenue This Year
$15.94
N/A
Revenue Next Year
$14.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.68
N/A
52 Week Low
$6.00
$7.48
52 Week High
$14.27
$32.41

Technical Indicators

Market Signals
Indicator
AMPL
BHVN
Relative Strength Index (RSI) 46.06 52.35
Support Level $6.00 $10.75
Resistance Level $7.74 $15.66
Average True Range (ATR) 0.58 0.65
MACD 0.19 -0.01
Stochastic Oscillator 87.93 45.38

Price Performance

Historical Comparison
AMPL
BHVN

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue primarily through selling subscriptions to the platform. The company derives a majority of its revenue from the United States.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: